Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development.
Saved in:
| Title: | Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development. |
|---|---|
| Authors: | Liu C; Aligos Therapeutics, Inc., South San Francisco, USA., Boland S; Cistim, Leuven, Belgium., Scholle MD; SAMDI Tech, Inc., Chicago, USA., Bardiot D; Cistim, Leuven, Belgium., Marchand A; Cistim, Leuven, Belgium., Chaltin P; Cistim, Leuven, Belgium; Centre for Drug Design and Discovery (CD3), KU Leuven, Leuven, Belgium., Blatt LM; Aligos Therapeutics, Inc., South San Francisco, USA., Beigelman L; Aligos Therapeutics, Inc., South San Francisco, USA., Symons JA; Aligos Therapeutics, Inc., South San Francisco, USA., Raboisson P; Aligos Belgium BV, Leuven, Belgium., Gurard-Levin ZA; SAMDI Tech, Inc., Chicago, USA., Vandyck K; Aligos Belgium BV, Leuven, Belgium., Deval J; Aligos Therapeutics, Inc., South San Francisco, USA. Electronic address: jdeval@aligos.com. |
| Source: | Antiviral research [Antiviral Res] 2021 Mar; Vol. 187, pp. 105020. Date of Electronic Publication: 2021 Jan 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33515606 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liu+C%22">Liu C</searchLink>; Aligos Therapeutics, Inc., South San Francisco, USA.<br /><searchLink fieldCode="AU" term="%22Boland+S%22">Boland S</searchLink>; Cistim, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Scholle+MD%22">Scholle MD</searchLink>; SAMDI Tech, Inc., Chicago, USA.<br /><searchLink fieldCode="AU" term="%22Bardiot+D%22">Bardiot D</searchLink>; Cistim, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Marchand+A%22">Marchand A</searchLink>; Cistim, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Chaltin+P%22">Chaltin P</searchLink>; Cistim, Leuven, Belgium; Centre for Drug Design and Discovery (CD3), KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Blatt+LM%22">Blatt LM</searchLink>; Aligos Therapeutics, Inc., South San Francisco, USA.<br /><searchLink fieldCode="AU" term="%22Beigelman+L%22">Beigelman L</searchLink>; Aligos Therapeutics, Inc., South San Francisco, USA.<br /><searchLink fieldCode="AU" term="%22Symons+JA%22">Symons JA</searchLink>; Aligos Therapeutics, Inc., South San Francisco, USA.<br /><searchLink fieldCode="AU" term="%22Raboisson+P%22">Raboisson P</searchLink>; Aligos Belgium BV, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Gurard-Levin+ZA%22">Gurard-Levin ZA</searchLink>; SAMDI Tech, Inc., Chicago, USA.<br /><searchLink fieldCode="AU" term="%22Vandyck+K%22">Vandyck K</searchLink>; Aligos Belgium BV, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Deval+J%22">Deval J</searchLink>; Aligos Therapeutics, Inc., South San Francisco, USA. Electronic address: jdeval@aligos.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228109699%22">Antiviral research</searchLink> [Antiviral Res] 2021 Mar; Vol. 187, pp. 105020. <i>Date of Electronic Publication: </i>2021 Jan 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8109699 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-9096 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201663542%22">01663542 </searchLink><i>NLM ISO Abbreviation: </i>Antiviral Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33515606 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.antiviral.2021.105020 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 105020 Titles: – TitleFull: Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu C – PersonEntity: Name: NameFull: Boland S – PersonEntity: Name: NameFull: Scholle MD – PersonEntity: Name: NameFull: Bardiot D – PersonEntity: Name: NameFull: Marchand A – PersonEntity: Name: NameFull: Chaltin P – PersonEntity: Name: NameFull: Blatt LM – PersonEntity: Name: NameFull: Beigelman L – PersonEntity: Name: NameFull: Symons JA – PersonEntity: Name: NameFull: Raboisson P – PersonEntity: Name: NameFull: Gurard-Levin ZA – PersonEntity: Name: NameFull: Vandyck K – PersonEntity: Name: NameFull: Deval J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2021 Mar Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1872-9096 Numbering: – Type: volume Value: 187 Titles: – TitleFull: Antiviral research Type: main |
| ResultId | 1 |